Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2
Published February 12, 2014 · Recall initiated: November 4, 2013
Summary
FDA records drug Class III recall D-1059-2014, published February 12, 2014 and initiated November 4, 2013. Recalling firm: Greenstone Llc; Status: Terminated; Reported quantity: 22,529 bottles; Lot: lot V112000, EXP Jun 2016. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Greenstone Llc
- Distributor
- US Nationwide (including PR)
- Lot
- lot V112000, EXP Jun 2016
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAmethylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only,February 4, 2026
- FDAVenlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottles, Rx only, Distributed by:June 18, 2014
- FDAGlucotrol XL (glipizide) extended release tablets, 5 mg, 100 count bottles, Rx only, Distributed by Roerig,February 12, 2014
- FDADiclofenac Sodium and Misoprostol Delayed-Release Tablets, 75mg/0.2mg, Rx only, Manufactured by WatsonFebruary 12, 2014
- FDANifedipine, extended-release tablets, 90mg 100 count blister pack, Rx only, Distributed by: GREENSTONE LLC,January 22, 2014
- FDASpironolactone tablets, USP 25 mg, Rx only, 500 count bottle, Distributed By: Greenstone LLC, Peapack, NJNovember 27, 2013
Questions about this recall
Was Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2 recalled?
Yes. FDA published recall D-1059-2014 on February 12, 2014. Reported hazard: Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval
What should I do if I have this product?
Voluntary: Firm initiated · Letter